ACCÈS RAPIDE AUX LIENS
The formation of stable highly organized protein aggegrates, known as amyloid fibrils, is associated with several debilitating human diseases, including Alzheimer's disease, Parkinson's disease, and Creutzfeldt-Jakob disease. In each of these conditions, a peptide or protein that is normally soluble accumulates into insoluble fibrils. Muscle acylphosphatase (AcP) has emerged as a significant model system to study protein misfolding and aggregation. It is particularly suitable for these studies because muscle AcP is a small, simple protein of only 98 amino acids consisting of a five-stranded antiparallel b-sheet and two parallel a-helices. Mutations in the muscle AcP between residues 16-31 and 87-98, which includes its phosphate binding site at Arg-23, significantly increases the rate of aggregation. These mutations correlate with changes in the hydrophobicity of AcP and a conversion of the a-helical structures to b-sheets. Therefore, a reduction in the net charge of a protein may be a key determinant in some forms of protein deposition diseases.
Informations pour la commande
Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps ACYP2 (G-5) | sc-398251 | 200 µg/ml | $316.00 | |||
ACYP2 (G-5): m-IgG Fc BP-HRP Kit | sc-538406 | 200 µg Ab; 10 µg BP | $354.00 | |||
ACYP2 (G-5): m-IgGκ BP-HRP Kit | sc-536015 | 200 µg Ab; 40 µg BP | $354.00 | |||
ACYP2 (G-5): m-IgG1 BP-HRP Kit | sc-545687 | 200 µg Ab; 20 µg BP | $354.00 |